1. Home
  2. MOGO vs IGC Comparison

MOGO vs IGC Comparison

Compare MOGO & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • IGC
  • Stock Information
  • Founded
  • MOGO 2003
  • IGC 2005
  • Country
  • MOGO Canada
  • IGC United States
  • Employees
  • MOGO N/A
  • IGC N/A
  • Industry
  • MOGO
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • IGC Health Care
  • Exchange
  • MOGO Nasdaq
  • IGC Nasdaq
  • Market Cap
  • MOGO 32.5M
  • IGC 29.4M
  • IPO Year
  • MOGO N/A
  • IGC N/A
  • Fundamental
  • Price
  • MOGO $1.25
  • IGC $0.31
  • Analyst Decision
  • MOGO Strong Buy
  • IGC Strong Buy
  • Analyst Count
  • MOGO 1
  • IGC 2
  • Target Price
  • MOGO $6.00
  • IGC $3.75
  • AVG Volume (30 Days)
  • MOGO 67.2K
  • IGC 390.0K
  • Earning Date
  • MOGO 03-19-2025
  • IGC 02-25-2025
  • Dividend Yield
  • MOGO N/A
  • IGC N/A
  • EPS Growth
  • MOGO N/A
  • IGC N/A
  • EPS
  • MOGO N/A
  • IGC N/A
  • Revenue
  • MOGO $30,995,226.00
  • IGC $1,236,000.00
  • Revenue This Year
  • MOGO N/A
  • IGC N/A
  • Revenue Next Year
  • MOGO $3.73
  • IGC $13.38
  • P/E Ratio
  • MOGO N/A
  • IGC N/A
  • Revenue Growth
  • MOGO N/A
  • IGC N/A
  • 52 Week Low
  • MOGO $0.94
  • IGC $0.27
  • 52 Week High
  • MOGO $2.25
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 46.89
  • IGC 42.69
  • Support Level
  • MOGO $1.17
  • IGC $0.29
  • Resistance Level
  • MOGO $1.30
  • IGC $0.33
  • Average True Range (ATR)
  • MOGO 0.07
  • IGC 0.01
  • MACD
  • MOGO -0.00
  • IGC 0.00
  • Stochastic Oscillator
  • MOGO 40.48
  • IGC 43.20

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: